CPC A61M 21/02 (2013.01) [A61K 31/137 (2013.01); A61K 38/07 (2013.01); A61P 25/04 (2018.01); A61M 2021/005 (2013.01); A61M 2021/0016 (2013.01); A61M 2021/0022 (2013.01); A61M 2021/0027 (2013.01); A61M 2021/0077 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/507 (2013.01)] | 20 Claims |
1. A combinatorial therapeutic system for treating and/or mitigating pain, comprising:
a therapeutically effective amount of an analgesic selected from tapentadol or difelikefalin (CR845); and
a computer system that includes at least one processor, computer-readable memory, and an output device, the computer system configured to provide an artificial sensory experience comprising one or more of a 2D artificial sensory experience, a 3D artificial sensory experience, a 4D artificial sensory experience, holography, augmented reality, virtual reality, or mixed reality,
wherein the output device is configured to produce, during the artificial sensory experience, sensory stimuli comprising a virtual representation of a patient's symptom that is perceptible to the patient, wherein the symptom includes pain, and
wherein the computer system is configured to cause the virtual representation of the patient's pain to perceptibly change during the artificial sensory experience.
|